Morpholinone and morpholine derivatives and uses thereof
AssigneeSynaptic Pharmaceutical Corporation
InventorsBharat Lagu, Dhanapalan Nagarathnam, Dake Tian, Charles Gluchowski
Life of this patent
Estimating the term…
Loading patent…
AssigneeSynaptic Pharmaceutical Corporation
InventorsBharat Lagu, Dhanapalan Nagarathnam, Dake Tian, Charles Gluchowski
Estimating the term…
This invention is directed to morpholinone and morpholine derivatives which are selective antagonists for human α1a receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia, sympathetic mediated pain, migraine, and for the treatment of any disease where the antagonism of the α1a receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.
A compound having the structure
Dependencies are inferred from the claim text.